A pioneering clinical trial explores whether two powerful immune molecules could change the future of HIV therapy.
Discover how the SORTS gene-editing method is transforming HIV research by identifying and isolating latent HIV reservoirs, opening new pathways for potential cures.
Discover how CRISPR gene editing and chemical selection create HIV-resistant immune cells, a breakthrough in functional cure research.
Exploring how subtle mutations in the Vif-associated proteasomal complex influence HIV susceptibility and potential therapeutic avenues.